Adjuvant Chemotherapy Including Cisplatin in Endometrial Carcinoma

Autor: Hidehiko Fujimura, Fumitaka Kikkawa, Hidenori Oguchi, Nobuo Nakashima, Shigehiko Mizutani
Rok vydání: 2000
Předmět:
Zdroj: Gynecologic and Obstetric Investigation. 50:127-132
ISSN: 1423-002X
0378-7346
DOI: 10.1159/000010297
Popis: To determine the outcome of patients with endometrial endometrioid adenocarcinoma following adjuvant chemotherapy, CAP (cyclophosphamide, pirarubicin and cisplatin) and EP (etoposide and cisplatin) were assigned at random to patients with Ic or more advanced stage carcinoma, and their efficacy was compared. These patients were treated by the Tokai Endometrial Cancer Study Group (Nagoya University and related institutions) between January 1992 and June 1996. The 5-year survival rate was 88.4% in the CAP group and 95.1% in the EP group; the difference between the two groups was not significant (p = 0.3496). The disease-free survival rate was 80.3% in the CAP group and 84.8% in the EP group (nonsignificant: p = 0.4533). However, the 5-year disease-free survival rates were 95.1 and 71.0% in patients with preoperative CA125 levels
Databáze: OpenAIRE